Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04317989
Other study ID # 19-1853
Secondary ID 1R18HS027078-01
Status Completed
Phase N/A
First received
Last updated
Start date January 22, 2020
Est. completion date October 31, 2023

Study information

Verified date November 2023
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

STUN Alcohol Use Now is an intervention designed to use primary care practice support services (practice facilitation) to help small to medium-size practices (10 or fewer providers) identify and provide services for people with unhealthy alcohol use. The original recruitment goal was 135 primary care practices in North Carolina, which we were unable to meet due to pandemic-related barriers.


Description:

STUN Alcohol Use Now is an intervention designed to use primary care practice support services (practice facilitation or PF) to help small to medium-size practices (10 or fewer providers) identify and provide services for people with unhealthy alcohol use. 135 primary care practices in North Carolina will be recruited. Specific Aim 1 will evaluate the effect of PF on uptake of evidence-based screening and brief intervention (SBI) for unhealthy alcohol use. The investigators hypothesize that PF will increase screening for unhealthy alcohol use and provision of brief counseling. The secondary hypothesis is that practice-level and contextual factors (capacity for quality improvement, organizational readiness to implement change, and implementation climate) will moderate the effect of PF on use of evidence-based screening and brief intervention (SBI) for unhealthy alcohol use. Specific Aim 2 will evaluate whether PF increases provision, among those identified as having an alcohol use disorder (AUD), provision of medication assisted treatment (MAT) or referral to specialty care. Aim 3 (effect of providing embedded telehealth services) will not be evaluated due to lower enrollment than anticipated and delayed data collection (both related to the COVID-19 pandemic) which have prevented randomization among practices with slower uptake of SBI after 6 months of PF. In Aim 4 the investigators will evaluate the effect of PF on the implementation of clinical practice and office systems changes to improve evidence-based SBI and MAT. The primary hypothesis is that PF will increase implementation of clinical practice and office systems changes to improve evidence-based SBI and MAT. The secondary hypotheses are that (a) practice capacity for quality improvement (QI), organizational readiness to implement change, and contextual factors will moderate the effect of PF on the implementation of clinical practice and office systems changes and (b) embedded telehealth services will increase implementation of clinical practice and office systems changes among practices with slower uptake.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date October 31, 2023
Est. primary completion date June 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Small-to-medium sized primary care practices (10 or fewer providers) in North Carolina Exclusion Criteria: - Practices with fewer than 100 adult patients (18+ years) or more than 10 providers; - practices unwilling to implement evidence-based screening and management of patients with unhealthy alcohol use.

Study Design


Intervention

Other:
Practice Facilitation
Implementing evidence-based protocols and the use of clinical algorithms (for screening, counseling, referral, and MAT) to engage the entire clinical team in a high standard delivery of care. Promoting a strong use of decision support tools and templates to support the practice workflow. Optimizing the use of the electronic health record (EHR) to pull clinical data on a monthly basis to guide the change process. Developing patient registries (e.g., for those identified to have AUD) to identify needed care Proactive, team-based care with assigned roles and responsibilities to prepare the clinical team to develop needed care and engage patients throughout the entire visit process. Enhancing the understanding of available counseling and referral resources to ensure that practices are confident that they have appropriate evidence-based intervention options.

Locations

Country Name City State
United States Mountain AHEC Asheville North Carolina
United States Charlotte AHEC Charlotte North Carolina
United States Greensboro AHEC Greensboro North Carolina
United States Eastern AHEC Greenville North Carolina
United States Wake AHEC Raleigh North Carolina
United States Area L AHEC Rocky Mount North Carolina
United States Southeast AHEC Wilmington North Carolina

Sponsors (2)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill Agency for Healthcare Research and Quality (AHRQ)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of adults screened for unhealthy alcohol use number aged 18 or older who were screened with a validated tool for unhealthy alcohol use 18 months
Primary Number of adults screened for unhealthy alcohol use number aged 18 or older who were screened with a validated tool for unhealthy alcohol use 12 months
Primary Number of adults screened for unhealthy alcohol use number aged 18 or older who were screened with a validated tool for unhealthy alcohol use 6 months
Primary Percent of adults screened for unhealthy alcohol use percent of those aged 18 or older who were screened with a validated tool for unhealthy alcohol use 18 months
Primary Percent of adults screened for unhealthy alcohol use percent of those aged 18 or older who were screened with a validated tool for unhealthy alcohol use 12 months
Primary Percent of adults screened for unhealthy alcohol use percent of those aged 18 or older who were screened with a validated tool for unhealthy alcohol use 6 months
Secondary Number of adults with a positive screen for unhealthy alcohol use Of those aged 18 or older who were screened for unhealthy alcohol use, number who had a positive initial screening result 18 months
Secondary Number of adults with a positive screen for unhealthy alcohol use Of those aged 18 or older who were screened for unhealthy alcohol use, number who had a positive initial screening result 12 months
Secondary Number of adults with a positive screen for unhealthy alcohol use Of those aged 18 or older who were screened for unhealthy alcohol use, number who had a positive initial screening result 6 months
Secondary Percent of adults with a positive screen for unhealthy alcohol use Of those aged 18 or older who were screened for unhealthy alcohol use, percentage who had a positive initial screening result 18 months
Secondary Percent of adults with a positive screen for unhealthy alcohol use Of those aged 18 or older who were screened for unhealthy alcohol use, percentage who had a positive initial screening result 12 months
Secondary Percent of adults with a positive screen for unhealthy alcohol use Of those aged 18 or older who were screened for unhealthy alcohol use, percentage who had a positive initial screening result 6 months
Secondary Number of adults provided with brief counseling for risky drinking Of those aged 18 or older who were identified as having unhealthy alcohol use, number who received brief counseling (based on documentation in the medical record) 18 months
Secondary Number of adults provided with brief counseling for risky drinking Of those aged 18 or older who were identified as having unhealthy alcohol use, number who received brief counseling (based on documentation in the medical record) 12 months
Secondary Number of adults provided with brief counseling for risky drinking Of those aged 18 or older who were identified as having unhealthy alcohol use, number who received brief counseling (based on documentation in the medical record) 6 months
Secondary Percent of adults provided with brief counseling for risky drinking Of those aged 18 or older who were identified as having unhealthy alcohol use, percentage who received brief counseling (based on documentation in the medical record) 18 months
Secondary Percent of adults provided with brief counseling for risky drinking Of those aged 18 or older who were identified as having unhealthy alcohol use, percentage who received brief counseling (based on documentation in the medical record) 12 months
Secondary Percent of adults provided with brief counseling for risky drinking Of those aged 18 or older who were identified as having unhealthy alcohol use, percentage who received brief counseling (based on documentation in the medical record) 6 months
Secondary Number of adults identified as having alcohol use disorder (AUD) After screening, number of adult patients identified to have AUD (based on documented ICD diagnoses of AUD) 18 months
Secondary Number of adults identified as having alcohol use disorder (AUD) After screening, number of adult patients identified to have AUD (based on documented ICD diagnoses of AUD) 12 months
Secondary Number of adults identified as having alcohol use disorder (AUD) After screening, number of adult patients identified to have AUD (based on documented ICD diagnoses of AUD) 6 months
Secondary Percent of adults identified as having alcohol use disorder (AUD) After screening, percentage of adult patients screened who were identified to have AUD (based on documented ICD diagnoses of AUD) 18 months
Secondary Percent of adults identified as having alcohol use disorder (AUD) After screening, percentage of adult patients screened who were identified to have AUD (based on documented ICD diagnoses of AUD) 12 months
Secondary Percent of adults identified as having alcohol use disorder (AUD) After screening, percentage of adult patients screened who were identified to have AUD (based on documented ICD diagnoses of AUD) 6 months
Secondary Number of adults prescribed pharmacotherapy for AUD After screening, number of adult patients with AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate 18 months
Secondary Number of adults prescribed pharmacotherapy for AUD After screening, number of adult patients with AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate 12 months
Secondary Number of adults prescribed pharmacotherapy for AUD After screening, number of adult patients with AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate 6 months
Secondary Percent of adults with AUD who were prescribed pharmacotherapy for AUD After screening, percent of adult patients identified as having AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate 18 months
Secondary Percent of adults with AUD who were prescribed pharmacotherapy for AUD After screening, percent of adult patients identified as having AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate 12 months
Secondary Percent of adults with AUD who were prescribed pharmacotherapy for AUD After screening, percent of adult patients identified as having AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate 6 months
Secondary Number of adults with AUD referred to specialty care for AUD After screening, number of adult patients identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs) 18 months
Secondary Number of adults with AUD referred to specialty care for AUD After screening, number of adult patients identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs) 12 months
Secondary Number of adults with AUD referred to specialty care for AUD After screening, number of adult patients identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs) 6 months
Secondary Percent of adults with AUD referred to specialty care for AUD After screening, percentage of adults identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs) 18 months
Secondary Percent of adults with AUD referred to specialty care for AUD After screening, percentage of adults identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs) 12 months
Secondary Percent of adults with AUD referred to specialty care for AUD After screening, percentage of adults identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs) 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT04788004 - Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse
Recruiting NCT05684094 - Mechanisms of Risky Alcohol Use in Young Adults: Linking Sleep to Reward- and Stress-Related Brain Function N/A
Completed NCT03406039 - Testing the Efficacy of an Online Integrated Treatment for Comorbid Alcohol Misuse and Emotional Problems N/A
Completed NCT03573167 - Mobile Phone-Based Motivational Interviewing in Kenya N/A
Completed NCT04817410 - ED Initiated Oral Naltrexone for AUD Phase 1
Active, not recruiting NCT04267692 - Harm Reduction Talking Circles for American Indians and Alaska Natives With Alcohol Use Disorders N/A
Completed NCT03872128 - The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders Phase 1
Recruiting NCT06030154 - Amplification of Positivity for Alcohol Use N/A
Active, not recruiting NCT05419128 - Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19 N/A
Completed NCT04564807 - Testing an Online Insomnia Intervention N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT04203966 - Mental Health and Well-being of People Who Seek Help From Their Member of Parliament
Recruiting NCT05861843 - Craving Assessment in Patients With Alcohol Use Disorder Using Virtual Reality Exposure
Terminated NCT04404712 - FAAH Availability in Psychiatric Disorders: A PET Study Early Phase 1
Enrolling by invitation NCT04128761 - Decreasing the Temporal Window in Individuals With Alcohol Use Disorder N/A
Not yet recruiting NCT06337721 - Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults N/A
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Enrolling by invitation NCT02544581 - Preliminary Analysis of the Soberlink Alcohol Breath Analyzer System's (SABA) Clinical Utility During Aftercare N/A
Completed NCT02511886 - A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder Phase 2
Active, not recruiting NCT02185131 - Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD. Phase 2